1. Phytochemicals Target Multiple Metabolic Pathways in Cancer
    Oleg Shuvalov et al, 2023, Antioxidants CrossRef
  2. In vitro characterization and molecular dynamic simulation of shikonin as a tubulin-targeted anticancer agent
    Gudapureddy Radha et al, 2022, Computers in Biology and Medicine CrossRef
  3. Shikonin Inhibits Oral Cancer Progression Through Suppression of Metastasis and Angiogenesis and Induction of Autophagy and Apoptosis
    Min Huan Wu et al, 2024, Jundishapur Journal of Natural Pharmaceutical Products CrossRef
  4. RNA methylation, metabolic reprogramming and pulmonary hypertension
    Li Hu et al, 2023, Chinese Science Bulletin CrossRef
  5. Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1
    Melissa Campos et al, 2023, Cancers CrossRef
  6. Targeting glycolysis in non-small cell lung cancer: Promises and challenges
    Jia-Qi Xu et al, 2022, Frontiers in Pharmacology CrossRef
  7. Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
    Yuting Cui et al, 2022, Frontiers in Pharmacology CrossRef
  8. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
    Abdul Waheed Khan et al, 2022, Cells CrossRef
  9. Bioinformatics Analysis and Verification of Metabolic Abnormalities in Esophageal Squamous Carcinoma
    Duo Tang et al, 2024, Combinatorial Chemistry & High Throughput Screening CrossRef
  10. Bioavailability and Pharmacological Properties of Shikonin‐ A Phytocompound from Lithospermum Erythrorhizon
    Stuti Biswal et al, 2024, ChemistrySelect CrossRef
  11. Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2‐mediated PI3K/AKT pathway
    Jiankun Ren et al, 2024, Chemical Biology & Drug Design CrossRef
  12. Circular RNA Sec61 subunit alpha isoform 1 by competitive absorption of microRNA‐513a‐5p mediates peroxisomal biogenesis factor 5 expression and promotes the malignant phenotype of non‐small cell lung cancer
    Zhe‐Ping Duan et al, 2023, The Kaohsiung Journal of Medical Sciences CrossRef
  13. Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression
    Krishna Yadav et al, 2022, OpenNano CrossRef
  14. Natural Plant-Derived Compounds in Food and Cosmetics: A Paradigm of Shikonin and Its Derivatives
    Sonia Malik et al, 2023, Materials CrossRef
  15. Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
    Birgit Lohberger et al, 2022, International Journal of Molecular Sciences CrossRef
  16. Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
    Birgit Lohberger et al, 2022, BMC Cancer CrossRef
  17. DDQN-based optimal targeted therapy with reversible inhibitors to combat the Warburg effect
    Jose M. Sanz Nogales et al, 2023, Mathematical Biosciences CrossRef
  18. Investigation of the effects of catharanthine and Q10 on Nrf2 and its association with MMP-9, MRP1, and Bcl-2 and apoptosis in a model of hepatocellular carcinoma
    Nafiseh Heidari-Kalvani et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  19. Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment
    Qiang Wang et al, 2021, Toxicology Research CrossRef
  20. Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma
    Kai-Fang Hu et al, 2023, Cancer Cell International CrossRef